Cutaneous angiosarcoma in a patient with xeroderma pigmentosum

Ilaria Marcon1, Paola Collini, Michela Casanova

  • 1Pediatric Oncology Unit, Istituto Nazionale Tumori, Milan, Italy.

Insights

Xeroderma pigmentosum (XP), a DNA repair defect, increases skin cancer risk. This report details a pediatric case of cutaneous angiosarcoma in a 15-year-old XP patient, successfully treated with surgery.

Area of Science:

  • Oncology
  • Genetics
  • Dermatology

Background:

  • Xeroderma pigmentosum (XP) is a rare genetic disorder characterized by deficient DNA repair mechanisms.
  • Individuals with XP have a significantly elevated risk of developing skin cancers, particularly on sun-exposed areas.
  • Soft tissue sarcomas are rare malignancies, and their association with XP is infrequently reported.

Observation:

  • This report presents a case of a 15-year-old male diagnosed with Xeroderma pigmentosum.
  • The patient developed a rare form of soft tissue sarcoma, specifically cutaneous angiosarcoma.
  • This represents the fourth documented instance of angiosarcoma in conjunction with XP and the third in a pediatric patient.

Findings:

  • The patient underwent surgical resection for the cutaneous angiosarcoma.
  • Despite incomplete tumor resection, the patient achieved a complete cure.
  • The patient remains disease-free for 40 months post-diagnosis, indicating a favorable outcome.

Implications:

  • This case highlights the potential for rare sarcoma development in XP patients.
  • It suggests that aggressive surgical management can be effective even with incomplete resection in select XP cases.
  • Further research into the oncogenic pathways in XP may reveal novel therapeutic targets for associated malignancies.